Medical Devices; Neurological Devices; Classification of the Prognostic Assessment Software of Mild Cognitive Impairment
By Human Services Department, Food, Health, Drug Administration · Nov 4, 2026, 11:00 PM CST
The Food and Drug Administration (FDA) is classifying the prognostic assessment software of mild cognitive impairment into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the prognostic assessment software of mild cognitive impairment. We are taking this action because we ha
Excerpt shown under fair-use limits. Full text remains with the original publisher.
People in this coverage
Explore their history and attributable record. Being mentioned does not imply endorsement.
Layer 1 · Claims & fact checks
AI analysisLayer 3 · Reporting analysis
AI analysisAppeal to AuthorityThe statement invokes the FDA's authority to lend credibility to the classification decision.
Positive FramingThe language frames the classification as a guarantee of safety, presenting the action in a favorable light.
Future Benefit ClaimThe claim projects a beneficial outcome without providing evidence, serving a persuasive purpose.
Context
AI analysisMissing context
The excerpt does not explain what specific special controls will apply, how the classification change will affect manufacturers, clinicians, or patients, nor does it provide data on the safety or effectiveness of the software.
Important context
FDA device classification determines the level of regulatory oversight; Class II devices require special controls in addition to general controls. Classification decisions are based on risk assessments and can impact market entry timelines.
Opinion vs. reporting
AI analysisThe text mixes factual reporting (classification decision) with evaluative language (e.g., "reasonable assurance of safety and effectiveness," "enhance patients' access," "reducing regulatory burdens"), which reflects an opinionated framing rather than pure reporting.